CoreFirst Bank & Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
CoreFirst Bank & Trust's PFE Position: Q1 2026 in Review
CoreFirst Bank & Trust reduced its Pfizer (PFE) stake by 15% in Q1 2026, selling an estimated $18.3K and leaving 3,811 shares worth $107K. The position accounts for 0.06% of the portfolio, ranked #154.
CoreFirst Bank & Trust first reported a position in PFE in Q4 2020 and has held it in 21 quarters since. The position peaked at $2.68M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- CoreFirst Bank & Trust held 3,811 shares of Pfizer worth $107K as of Q1 2026.
- CoreFirst Bank & Trust sold 686 Pfizer shares in Q1 2026, an estimated $18.3K.
- Pfizer made up 0.06% of CoreFirst Bank & Trust's portfolio in Q1 2026, its #154 holding.
- CoreFirst Bank & Trust first reported a position in Pfizer in Q4 2020 and has held it in 21 quarters since.
- CoreFirst Bank & Trust's Pfizer position peaked at $2.68M in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on CoreFirst Bank & Trust's 13F filing for Q1 2026, filed 3 Jun 2026.